Five and Under

[sd3]

PNSA NEWS!!.. Ponte Nossa Acquires Visijet




Business Editors/Health & Medical Writers

IRVINE, Calif.--(BW HealthWire)--Ponte Nossa Acquisition Corp.
(OTCBB:PNSA) announced today that they have successfully negotiated
the acquisition of Visijet, Inc., a privately-held ophthalmic medical
device company located in Irvine.
Visijet, founded in 1996, is the developer of an exciting new
technology that uses a high pressure micro beam of water to perform
surgical cuts for ocular procedures -- similarly to how a laser uses
light to dissect tissue. The company's first product, approved by the
FDA in October, 2000 is the Hydrokeratome(R), an innovative, patented
device that offers "bladeless" surgery to perform the cutting of the
cornea that is required in LASIK surgery. LASIK surgery is a procedure
growing in popularity that allows individuals to have corrected visual
acuity without glasses or contact lenses. It is estimated that more
than 3 million LASIK surgeries were performed last year worldwide.
Visijet's second product, the Pulsatome(R), is a device that uses
the waterjet technology to remove cataracts -- the most performed
surgical procedure in the world. The Pulsatome(R) will provide entry
into an estimated $8 billion cataract market worldwide. FDA approval
for the device is anticipated in early 2002. In addition, Visijet has
several ophthalmic devices utilizing the waterjet technology under
development.
"We are very excited about Visijet," said Thomas F. DiMele,
president of Ponte Nossa. "The advantages the technology offers over
products currently available are significant and the company's
intellectual properties, management, R&D, and distribution channels
are well established. We look forward to significant growth."
Specifics of the transaction to be announced in a timely manner.

Forward-Looking Statement

Except for historical information contained herein, the matters
discussed in this news release are forward-looking statements within
the meaning of the Securities Exchange Act that involve risks and
uncertainties that could cause actual results to differ materially
from those expressed. These matters include, but are not limited to,
information about the Company's technologies and products, financial
situations, or business opportunities. This news release shall not
constitute an offer to sell or the solicitation of an offer to sell
any of these securities.

--30--sdc/sf* jr/sf

CONTACT: Mitchell & Company (for Ponte Nossa)
Diane Mitchell, 949/474-7020

KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: MEDICAL MEDICAL DEVICES MERGERS/ACQ

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com





Jul-23-2001 12:07 GMT
Symbols:
US;PNSA
Source BW Business Wire
Categories:
MST/R/US/CA MST/I/MTC MST/I/MTC